Anaerobic pleuropulmonary infection

Infectious Diseases in Clinical Practice

Volumn 11, Issue 3, 2002, Pages 131-136

  Levison, Matthew E ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845648224     PISSN: 10569103     EISSN: 15369943     Source Type: Journal    
DOI: 10.1097/00019048-200203000-00006     Document Type: Article

References (29)

1. Levison ME, Bran JL, Ries K. Treatment of anaerobic bacterial infections with clindamycin 2 phosphate. Antimicrob Agents Chemother 1974; 5: 276-280.
2. Cesar L, Gonzalez C, Calia FM. Bacteriologic flora of aspiration-induced pulmonary infections. Arch Intern Med 1975; 135: 711-714.
3. Lorber B, Swenson RM. Bacteriology of aspiration pneumonia, a prospective study of community and hospital acquired cases. Ann Intern Med 1974; 81:329.
4. Bartlett JG, O’Keefe P, Tally FP, et al. Bacteriology of hospital-acquired pneumonia. Arch Intern Med 1986; 146: 868-871.
5. Bartlett JG, Gorbach SL, Finegold SM. The bacteriology of aspiration pneumonia. Am J Med 1974; 56: 202-207.
6. Bartlett JG, Gorbach SL. Treatment of aspiration pneumonia and primary lung abscess: penicillin G vs. clindamycin. JAMA 1975; 234: 935-937.
7. Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: special needs for fastidious organisms and difficult to detect resistance mechanisms. Clin Infect Dis 2000; 30: 799-808.
8. Slots J. Subgingival microflora and periodontitis. J Clin Periodont 1979; 6: 351-382.
9. Marina M, Strong CA, Civen R, et al. Bacteriology of anaerobic pleuropulmonary infection. Preliminary Report. Clin Infect Dis 1993; 16 (suppl 4):S256-S262.
10. Pollack HM, Hawkins EL, Bonner JR, et al. Diagnosis of bacterial pulmonary infections with quantitative protected catheter cultures obtained during bronchoscopy. J Clin Microbiol 1983; 17: 255-259.
11. Dore P, Robert R, Grolier G, et al. Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush. Am J Resp Crit Care Med 1996; 153: 1292-1298.
12. Mier L, Dreyfuss D, Darchy B, et al. Is penicillin G adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures. Intensive Care Med 1993; 19: 279-284.
13. Marik PE, Careau P. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia, a prospective study. Chest 1999; 115: 178-183.
14. Bartlett JG. Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis 1993; 16 (suppl 4):S248-S255.
15. Levison ME, Mangura CT, Lorber B, et al. Clindamycin compared with penicillin for the treatment of anaerobic hung abscess. Ann Intern Med 1983; 98: 466-471.
16. Gudiol F, Manresa F, Pallares R, et al. Clindamycin vs. penicillin for anaerobic hung infections. High rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus. Arch Intern Med 1990; 150: 2525-2529.
17. Kasten MJ. Clindamycin, metronidazole and chloramphenicol. Mayo Chin Proc 1999; 74: 825-833.
18. Falagas ME, Siakavellas E. Bacteroides, Prevotella and Porphyromonas species: a review of antibiotic resistance and therapeutic options. Int J Antimicrob Agents 2000; 15: 1-9.
19. Perlino CA. Metronidazole vs. clindamycin treatment of anaerobic pulmonary infection: failure of metronidazole therapy. Arch Intern Med 1981; 141: 1424-1427.
20. Appelbaum PC. Quinolone activity against anaerobes. Drugs 1999; 58: 60-64.
21. Schaumann R, Ackerman G, Pless B, et al. In-vitro activities of gatifoxacin, two other quinolones, and five nonquinolone antimicrobials against obligately anaerobic bacteria. Antimicrob Agents Chemother 1999; 43: 2783-2786.
22. Goldstein EJ. Review of the in vitro activity of gemifloxacin against Gram-positive and Gram-negative anaerobic pathogens. J Antimicrob Chemother 2000; 45: 55-65.
23. Goldstein EJ, Citron DM, Vreni Merriam C, et al. Activities of gemifloxacin (SB 265805, LB 20304) compared to those of other oral antimicrobial agents against unusual anaerobes. Antimicrob Agents Chemother 1999; 43: 2726-2730.
24. Goldstein EJ, Citron DM, Merriam CV, et al. Activity of gatifloxacin compared to five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infections. Antimicrob Agents Chemother 1999; 43: 1475-1479.
25. Ackerman G, Schaumann R, Pless B, et al. Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria. Eur J Clin Microbiol Infect Dis 2000; 19: 228-232.
26. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000; 31:347.
27. Heffelfinger JD, Dowell SF, Jorgensen JH, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance. A report from the drug-resistant Streptococcus pneumoniae therapeutic working group. Arch Intern Med 2000; 160:1400.
28. Goldstein EJ, Citron DM, Merriam CV, et al. Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes. Antimicrob Agents Chemother 1999; 43: 2801-2805.
29. Goldstein F, Citron DM, Merriam CV. Linezolid activity compared to those of other selected macrolides and other agents against aerobic and anaerobic pathogens isolated from soft tissues bite infections in humans. Antimicrob Agents Chemother 1999; 43: 1469-1474.